| Display title | Medicine:Cancer biomarker | 
| Default sort key | Cancer biomarker | 
| Page length (in bytes) | 48,319 | 
| Namespace ID | 3048 | 
| Namespace | Medicine | 
| Page ID | 868133 | 
| Page content language | en - English | 
| Page content model | wikitext | 
| Indexing by robots | Allowed | 
| Number of redirects to this page | 0 | 
| Counted as a content page | Yes | 
| Page image |  | 
| HandWiki item ID | None | 
| Edit | Allow all users (infinite) | 
| Move | Allow all users (infinite) | 
| Page creator | imported>StanislovAI | 
| Date of page creation | 02:06, 5 February 2024 | 
| Latest editor | imported>StanislovAI | 
| Date of latest edit | 02:06, 5 February 2024 | 
| Total number of edits | 1 | 
| Recent number of edits (within past 90 days) | 0 | 
| Recent number of distinct authors | 0 | 
| Description | Content | 
| Article description: ( description)This attribute controls the content of the
 descriptionandog:descriptionelements. | A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for... |